OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
May 20, 2020
This latest round of funding adds 14 new technology projects, workforce development, and Global Health Fund projects to NIIMBL's portfolio.
May 19, 2020
Participants in two dosing cohorts in Moderna’s mRNA-1273 study reached or exceeded neutralizing antibody titers generally seen in convalescent sera.
May 05, 2020
Catalent will manufacture a mRNA-based COVID-19 vaccine for clinical trials and potential commercialization.
FDA/FTC collaborate to end false and misleading statements and discuss the future of biosimilars at March 2020 public workshop on a competitive marketplace for biosimilars.
May 02, 2020
FDA’s EUA provides the first new treatment for COVID-19 patients with severe symptoms.
May 01, 2020
Will moving at “warp speed” to develop a vaccine impact efficacy or safety?
Having remote operations in place is crucial to maintaining good automation practices.
Viral vectors show promise as a delivery mechanism for gene therapy, but which virus types are commercially viable?
But are innovations sufficient to increase adoption? CMOs are demanding better continuous bioprocessing options.
April 29, 2020
NIH trial shows remdesivir accelerates recovery; Gilead study shows similar efficacy for 5- and 10-day dosing.